Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanchon Bourasset

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Life Sciences|November 29, 2005
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronideFanchon Bourasset, Jean-Michel Scherrmann
Journal of General Internal Medicine|June 16, 2021
Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic AnalysesBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of Epidemiology and Global Health|November 4, 2021
Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 SpreadBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of General Internal Medicine|January 14, 2021
Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic ToolsBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of Neurochemistry|September 3, 2003
Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrierFanchon Bourasset, Salvatore Cisternino, Jamal Temsamani, et al.
Handbook of Experimental Pharmacology|January 21, 2021
Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species DifferencesFanchon Bourasset, Sylvain Auvity, Robert G Thorne, et al.
Cancer Research|May 6, 2004
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrierSalvatore Cisternino, Claire Mercier, Fanchon Bourasset, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 2005
Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the ratFanchon Bourasset, Katy Bernard, Carmen Muñoz, et al.
Molecular Pharmaceutics|November 13, 2013
Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusionWael Alata, Sarah Paris-Robidas, Vincent Emond, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 3, 2012
Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticlesKhairallah Alhareth, Christine Vauthier, Fanchon Bourasset, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Life Sciences|November 29, 2005
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronideFanchon Bourasset, Jean-Michel Scherrmann
Journal of General Internal Medicine|June 16, 2021
Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic AnalysesBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of Epidemiology and Global Health|November 4, 2021
Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 SpreadBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of General Internal Medicine|January 14, 2021
Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic ToolsBruno Mégarbane, Fanchon Bourasset, Jean-Michel Scherrmann
Journal of Neurochemistry|September 3, 2003
Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrierFanchon Bourasset, Salvatore Cisternino, Jamal Temsamani, et al.
Handbook of Experimental Pharmacology|January 21, 2021
Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species DifferencesFanchon Bourasset, Sylvain Auvity, Robert G Thorne, et al.
Cancer Research|May 6, 2004
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrierSalvatore Cisternino, Claire Mercier, Fanchon Bourasset, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 2005
Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the ratFanchon Bourasset, Katy Bernard, Carmen Muñoz, et al.
Molecular Pharmaceutics|November 13, 2013
Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusionWael Alata, Sarah Paris-Robidas, Vincent Emond, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 3, 2012
Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticlesKhairallah Alhareth, Christine Vauthier, Fanchon Bourasset, et al.
Pageof 4